Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization.

MLA

Zhang, Rutan, et al. “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus Aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization.” Clinical Infectious Diseases, vol. 75, no. 9, Nov. 2022, pp. 1641–44. EBSCOhost, https://doi.org/10.1093/cid/ciac341.

APA

Zhang, R., Polenakovik, H., Beltran, I. A. B., Waalkes, A., Salipante, S. J., Xu, L., & Werth, B. J. (2022). Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization. Clinical Infectious Diseases, 75(9), 1641–1644. https://doi.org/10.1093/cid/ciac341

Chicago

Zhang, Rutan, Hari Polenakovik, Ismael A Barreras Beltran, Adam Waalkes, Stephen J Salipante, Libin Xu, and Brian J Werth. 2022. “Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus Aureus in a Patient Treated With Dalbavancin: Case Report and Isolate Characterization.” Clinical Infectious Diseases 75 (9): 1641–44. doi:10.1093/cid/ciac341.